<?xml version="1.0" encoding="UTF-8"?>
<akn:akomaNtoso xmlns:akn="http://docs.oasis-open.org/legaldocml/ns/akn/3.0"><akn:act><akn:meta><akn:identification source="#cosilico"><akn:FRBRWork prescriptive="true" authoritative="true"><akn:FRBRuri value="/akn/us/usc/42/299b–35" /><akn:FRBRdate date="2025-12-31" name="retrieval" /><akn:FRBRauthor href="#us-congress" /><akn:FRBRcountry value="us" /></akn:FRBRWork><akn:FRBRExpression><akn:FRBRuri value="/akn/us/usc/42/299b–35/eng@2025" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /><akn:FRBRlanguage language="en" /></akn:FRBRExpression><akn:FRBRManifestation><akn:FRBRuri value="/akn/us/usc/42/299b–35/eng@2025/main.xml" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /></akn:FRBRManifestation></akn:identification></akn:meta><akn:body><akn:section eId="sec_299b_35"><akn:num>299b–35</akn:num><akn:heading>Grants or contracts to implement medication management services in treatment of chronic diseases</akn:heading><akn:content><akn:p>§ 299b–35. Grants or contracts to implement medication management services in treatment of chronic diseases(a) In generalThe Secretary, acting through the Patient Safety Research Center established in section 299b–33 of this title (referred to in this section as the “Center”), shall establish a program to provide grants or contracts to eligible entities to implement medication management (referred to in this section as “MTM”) services provided by licensed pharmacists, as a collaborative, multidisciplinary, inter-professional approach to the treatment of chronic diseases for targeted individuals, to improve the quality of care and reduce overall cost in the treatment of such diseases. The Secretary shall commence the program under this section not later than May 1, 2010.


(b) Eligible entitiesTo be eligible to receive a grant or contract under subsection (a), an entity shall—(1) provide a setting appropriate for MTM services, as recommended by the experts described in subsection (e);

(2) submit to the Secretary a plan for achieving long-term financial sustainability;

(3) where applicable, submit a plan for coordinating MTM services through local community health teams established in section 256a–1 of this title or in collaboration with primary care extension programs established in section 280g–12 of this title;

(4) submit a plan for meeting the requirements under subsection (c); and

(5) submit to the Secretary such other information as the Secretary may require.


(c) MTM services to targeted individualsThe MTM services provided with the assistance of a grant or contract awarded under subsection (a) shall, as allowed by State law including applicable collaborative pharmacy practice agreements, include—(1) performing or obtaining necessary assessments of the health and functional status of each patient receiving such MTM services;

(2) formulating a medication treatment plan according to therapeutic goals agreed upon by the prescriber and the patient or caregive</akn:p></akn:content><akn:subsection eId="subsec_299b_35_a"><akn:num>(a)</akn:num><akn:heading>In general</akn:heading><akn:content><akn:p>(a) In general The Secretary, acting through the Patient Safety Research Center established in section 299b–33 of this title (referred to in this section as the “Center”), shall establish a program to provide grants or contracts to eligible entities to implement medication management (referred to in this section as “MTM”) services provided by licensed pharmacists, as a collaborative, multidisciplinary, inter-professional approach to the treatment of chronic diseases for targeted individuals, to improve the quality of care and reduce overall cost in the treatment of such diseases. The Secretary shall commence the program under this section not later than May 1, 2010.</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_299b_35_b"><akn:num>(b)</akn:num><akn:heading>Eligible entities</akn:heading><akn:content><akn:p>(b) Eligible entities To be eligible to receive a grant or contract under subsection (a), an entity shall—</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_299b_35_c"><akn:num>(c)</akn:num><akn:heading>MTM services to targeted individuals</akn:heading><akn:content><akn:p>(c) MTM services to targeted individuals The MTM services provided with the assistance of a grant or contract awarded under subsection (a) shall, as allowed by State law including applicable collaborative pharmacy practice agreements, include—</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_299b_35_d"><akn:num>(d)</akn:num><akn:heading>Targeted individuals</akn:heading><akn:content><akn:p>(d) Targeted individuals MTM services provided by licensed pharmacists under a grant or contract awarded under subsection (a) shall be offered to targeted individuals who—</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_299b_35_e"><akn:num>(e)</akn:num><akn:heading>Consultation with experts</akn:heading><akn:content><akn:p>(e) Consultation with experts In designing and implementing MTM services provided under grants or contracts awarded under subsection (a), the Secretary shall consult with Federal, State, private, public-private, and academic entities, pharmacy and pharmacist organizations, health care organizations, consumer advocates, chronic disease groups, and other stakeholders involved with the research, dissemination, and implementation of pharmacist-delivered MTM services, as the Secretary determines appropriate. The Secretary, in collaboration with this group, shall determine whether it is possible to incorporate rapid cycle process improvement concepts in use in other Federal programs that have implemented MTM services.</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_299b_35_f"><akn:num>(f)</akn:num><akn:heading>Reporting to the Secretary</akn:heading><akn:content><akn:p>(f) Reporting to the Secretary An entity that receives a grant or contract under subsection (a) shall submit to the Secretary a report that describes and evaluates, as requested by the Secretary, the activities carried out under subsection (c), including quality measures endorsed by the entity with a contract under section 1395aaa of this title, as determined by the Secretary.</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_299b_35_g"><akn:num>(g)</akn:num><akn:heading>Evaluation and report</akn:heading><akn:content><akn:p>(g) Evaluation and report The Secretary shall submit to the relevant committees of Congress a report which shall—</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_299b_35_h"><akn:num>(h)</akn:num><akn:heading>Grants or contracts to fund development of performance measures</akn:heading><akn:content><akn:p>(h) Grants or contracts to fund development of performance measures The Secretary may, through the quality measure development program under section 299b–31 of this title, award grants or contracts to eligible entities for the purpose of funding the development of performance measures that assess the use and effectiveness of medication therapy management services.</akn:p></akn:content></akn:subsection></akn:section></akn:body></akn:act></akn:akomaNtoso>